Business Wire

Therapeutic Solutions International Files Investigational New Drug Application for Treatment of Chronic Obstructive Pulmonary Disease (COPD) Using JadiCell™ Universal Donor ...

OCEANSIDE, Calif.--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. announced today filing of an Investigational New Drug (IND) application with the United States Food and Drug ...
Business Wire

Therapeutic Solutions International Reports Superior Efficacy of ApoptoCyte™ on Chronic Obstructive Pulmonary Disease Model Compared to Conventional Stem Cell Approaches

ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International announced today new data demonstrating superior effects of the Company’s ApoptoCyte™ procedure treated JadiCell™ product compared ...
UC San Francisco

Susceptibility to Pathogenic T Cells in Chronic Lung Disease May Have Genetic Basis

Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue ...
Nasdaq

Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing Chronic Obstructive Pulmonary Disease (COPD)

ELK CITY, Idaho--(BUSINESS WIRE)-- Therapeutic Solutions International (TSOI) announced today the launching of a spin-off company, Breathe Biologics, Inc., to commercialize technologies in the area of ...
The American Journal of Managed Care

COPD Prevalence Did Not Significantly Change Overall From 2011 to 2021, Study Says

Based on Behavioral Risk Factor Surveillance System data, about 6.4% of US adults in 2011 (14.3 million people) and about 6.5% (14.2 million) had COPD in 2021, showing that COPD prevalence did not ...
technologynetworks

COPD as a Lung Stem Cell Disease

Two internationally renowned stem cell experts have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), a leading cause of ...